Why These 15 Big-Cap Stocks Are Plunging So Far in 2025

Page 4 of 14

11. Danaher Corp (NYSE:DHR)

Number of Hedge Fund Holders In Q4 2024: 101

Danaher Corp (NYSE:DHR) is a diversified company that makes medical, industrial, and commercial products. It mostly focuses on life sciences and biotechnology.

The stock is down significantly so far in 2025 as Danaher missed its Q4 2024 EPS target by 5.5%. It reported $5.29 instead of the expected $5.57.

Revenue for the quarter was $6.54 billion, which was above expectations but slower than that of Danaher’s peers. Analysts lowered their expectations for all of 2025 following the report and now project only 1.1% revenue growth.

Not only that, Danaher itself projected a low-single-digit contraction in non-GAAP core revenue for Q1 2025 compared to the prior year period. It also faces risks in its China market.

The consensus price target of $278 implies 35% upside.

DHR stock is down 10.30% year-to-date.

Page 4 of 14